amantadine has been researched along with physostigmine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
| Agnoli, A; Squitieri, G | 1 |
| Berkowitz, CD | 1 |
| Casey, DE | 1 |
| Agnoli, A; Aloisi, P; Cappenberg, L; Cerone, G; Ruggieri, S | 1 |
| Baran, L; Maj, J; Sowińska, H | 1 |
| Fincke, M; Gothóni, P; Lehtinen, M | 1 |
2 review(s) available for amantadine and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Memory, biochemical and pharmacological problems].
Topics: Amantadine; Amphetamine; Brain; Catecholamines; Humans; Levodopa; Memory, Short-Term; Paired-Associate Learning; Physostigmine; Reserpine | 1977 |
11 other study(ies) available for amantadine and physostigmine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
Treatment of acute amantadine toxicity with physostigmine.
Topics: Amantadine; Child, Preschool; Female; Humans; Physostigmine | 1979 |
Amantadine intoxication reversed by physostigmine.
Topics: Aged; Amantadine; Humans; Male; Physostigmine | 1978 |
[Pharmacological study of parkinsonian tremor. II. Role of the dopamine-acetylcholine system].
Topics: Acetylcholine; Aged; Amantadine; Brain; Dopamine; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease, Secondary; Physostigmine; Piperazines; Tranquilizing Agents | 1977 |
Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
Topics: Amantadine; Animals; Anthracenes; Catalepsy; Drug Synergism; Female; Humans; Levodopa; Male; Physostigmine; Piperidines; Rats; Receptors, Drug; Reserpine; Serotonin; Tranquilizing Agents | 1976 |
Drugs for Parkinson's disease reduce tremor induced by physostigmine.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor | 1983 |